DOVER Corp
No SEC Form 4 filings for $DOV in the last 30 days.
Dover Corporation (NYSE: DOV) said its board increased the quarterly cash dividend to $0.525 per share from $0.52. The payment is scheduled for Sept. 15, 2026, to shareholders of record as of Aug. 31, 2026. Dover cited this as its 71st consecutive annual dividend increase.
Jim Cramer’s Charitable Trust plans to sell 90 shares of Dover (DOV) around $204, cutting its DOV weighting to 1% from about 1.5%. It will buy 60 shares of Johnson & Johnson (JNJ) around $253, raising JNJ weighting to about 2.55%. The article also says the trust is eyeing Intel (INTC) and Corning (GLW).
According to Linklaters, Dover Corporation has signed a definitive agreement to acquire Cloeren Incorporated. The report says Linklaters advised Dover on the transaction. The deal’s impact for investors depends on deal terms, timing, and regulatory approvals.
Over the past 7 days, alphai's AI scored 3 news stories mentioning DOV (DOVER Corp). Coverage has skewed bullish: 2 bullish, 1 neutral, and 0 bearish.
Recent DOV coverage spans mergers & acquisitions, market movers and financial news.
A small dividend hike signals continued capital return, typically supportive for income-focused positioning but unlikely to drive large repricing.
The article signals a position trim tied to a prior operational issue in Dover's CO2 refrigeration production ramp.
Deal announcement should reprice Dover on deal terms, financing assumptions, and integration risk, with near-term volatility likely.
The disclosed, definitive acquisition agreement is a direct balance-sheet and valuation catalyst for DOV, with deal-close timing in Q3 2026.
Mixed catalyst for DOV: small acquisition headline versus negative recent execution/downgrade context.
alphai scores every news story that mentions DOV with an AI model for sentiment and relevance, and aggregates insider trades from DOVER Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Dover Corporation (NYSE: DOV) said its board increased the quarterly cash dividend to $0.525 per share from $0.52. The payment is scheduled for Sept. 15, 2026, to shareholders of record as of Aug. 31, 2026. Dover cited this as its 71st consecutive annual dividend increase.
1 min readJim Cramer’s Charitable Trust plans to sell 90 shares of Dover (DOV) around $204, cutting its DOV weighting to 1% from about 1.5%. It will buy 60 shares of Johnson & Johnson (JNJ) around $253, raising JNJ weighting to about 2.55%. The article also says the trust is eyeing Intel (INTC) and Corning (GLW).
4 min readAccording to Linklaters, Dover Corporation has signed a definitive agreement to acquire Cloeren Incorporated. The report says Linklaters advised Dover on the transaction. The deal’s impact for investors depends on deal terms, timing, and regulatory approvals.
1 min readDover (according to the company) signed an agreement to acquire Cloeren, a maker of extrusion T-dies and feedblocks for polymer and plastics processing. Terms were not disclosed. The deal is expected to close in Q3 2026, subject to conditions, and Cloeren will join Dover’s MAAG unit in the Pumps and Process Solutions segment. Dover has $8B+ annual revenue.
4 min readCNBC’s Investing Club says the Dow rose over 500 points (about 1.1%) while the S&P 500 gained ~0.25% and the Nasdaq fell for a fifth straight day. Coca-Cola, Sherwin-Williams, and Boeing rallied on earnings and free cash flow. The note covers AI stock weakness, Dover’s acquisition of Cloeren, and upcoming earnings from Seagate, KLA, Bloom Energy, Visa, Ford, and others.
7 min readDover announced it will acquire flat die maker Cloeren, according to the article. The deal involves Dover and Cloeren, with the acquisition positioned as part of Dover’s business expansion in flat die manufacturing. Investors may track the transaction for potential impact on Dover’s industrial segment and future earnings.
3 min readDover Corporation (NYSE: DOV) said it signed a definitive agreement to acquire Cloeren Incorporated, adding extrusion T-dies and feedblocks to the MAAG business unit in Dover’s Pumps & Process Solutions segment. Cloeren will be based in Orange, Texas, with other sites in Texas, Wisconsin, and Austria. The deal is expected to close in Q3; terms were not disclosed.
3 min readStocks fell for a second straight week, with the S&P 500 down 0.6% and the Nasdaq down 2.1%, as oil rose on Middle East tensions and inflation-rate expectations increased. Alphabet shares fell after capex guidance rose to $195B-$205B. Intel gained on data center revenue growth. GE Vernova, Dover, Eli Lilly, and Johnson & Johnson also moved on earnings and FDA/clinical updates.
7 min readWall Street Zen downgraded Dover (NYSE:DOV) from buy to hold in a Saturday research note. Other analysts cited include Deutsche Bank (hold, $229 target), Seaport Research (buy, raised to $265), and Citigroup (buy). Dover shares opened at $202.45. In the latest quarter, Dover reported $2.74 EPS and $2.19B revenue, and set FY2026 EPS guidance of 10.55 to 10.75.
4 min readWall Street analysts issued multiple rating changes. Truist upgraded PayPal (PYPL) to Hold, $57 target; Leerink upgraded Edwards Lifesciences (EW) to Outperform, $101. TD Cowen upgraded Digital Realty (DLR) to Buy, $222; Morgan Stanley upgraded Progressive (PGR) to Equal Weight, $210. Several downgrades followed, including Infosys (INFY) and Albertsons (ACI). Coverage initiations included SpaceX (SPCX) and Chime (CHYM).
2 min read
